DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
193	プラダー・ウィリ症候群	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01038570 (ClinicalTrials.gov)	June 2009	16/11/2009	Comparative Study Between Prader-Willi Patients Who Take Oxytocin Versus Placebo	Evaluation of the Effect of the Oxytocin Administered in Nasal Pulverizing on the Social Skills, the Stress, the Anxiety and the Eating Habits at Grown-up Patients Presenting a Syndrome of Prader-Willi: Pilot Study	Prader Willi Syndrome	Drug: Syntocinon®/- Spray;Drug: Physiological serum (Sodium chloride)	University Hospital, Toulouse	NULL	Completed	18 Years	N/A	All	24	Phase 2	France

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT01038570
(ClinicalTrials.gov)

June 2009

16/11/2009

Comparative Study Between Prader-Willi Patients Who Take Oxytocin Versus Placebo

Evaluation of the Effect of the Oxytocin Administered in Nasal Pulverizing on the Social Skills, the Stress, the Anxiety and the Eating Habits at Grown-up Patients Presenting a Syndrome of Prader-Willi: Pilot Study

Prader Willi Syndrome

Drug: Syntocinon®/- Spray;Drug: Physiological serum (Sodium chloride)

University Hospital, Toulouse

NULL

Completed

18 Years

N/A

All

Phase 2

France